Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fort Myers, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Hialeah, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Jacksonville, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Kissimmee, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Lakeland, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Lakeland, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Leesburg, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Leesburg, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Miami, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
New Port Richey, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Ocala, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Orlando, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Ormond Beach, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Royal Palm Beach, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Royal Palm Beach, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Sunrise, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Tampa, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Alpharetta, GA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Columbus, GA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Savannah, GA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Smyrna, GA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Bolingbrook, IL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Bolingbrook, IL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Chicago, IL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Gurnee, IL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Melrose Park, IL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Melrose Park, IL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Oak Brook, IL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Oak Brook, IL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Evansville, IN
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Indianapolis, IN
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
West Des Moines, IA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
West Des Moines, IA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Newton, KA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Newton, KA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Wichita, KA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Lexington, KY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Paducah, KY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Lake Charles, LA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Boston, MA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fall River, MA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fall River, MA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
New Bedford, MA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
New Bedford, MA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Watertown, MA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Watertown, MA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Biloxi, MS
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Biloxi, MS
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Hazelwood, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Hazelwood, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Kansas City, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Springfield, MO
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Billings, MT
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Omaha, NE
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Las Vegas, NV
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Berlin, NJ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Blackwood, NJ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Blackwood, NJ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Albuquerque, NM
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Manhasset, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
New York, NY
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials